| Ticker Details |
Theravance Biopharma, Inc.
Theravance Biopharma Inc is a diversified biopharmaceutical company. It is engaged in discovery, research, development and commercialization of human therapeutics.
|
| IPO Date: |
May 16, 2014 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$996.22M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.40 | 2.11%
|
| Avg Daily Range (30 D): |
$0.33 | 1.69%
|
| Avg Daily Range (90 D): |
$0.31 | 1.71%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.34M |
| Avg Daily Volume (30 D): |
.3M |
| Avg Daily Volume (90 D): |
.35M |
| Trade Size |
| Avg Trade Size (Sh.): |
90 |
| Avg Trade Size (Sh.) (30 D): |
41 |
| Avg Trade Size (Sh.) (90 D): |
45 |
| Institutional Trades |
| Total Institutional Trades: |
2,180 |
| Avg Institutional Trade: |
$1.39M |
| Avg Institutional Trade (30 D): |
$1.1M |
| Avg Institutional Trade (90 D): |
$1.36M |
| Avg Institutional Trade Volume: |
.08M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.16M |
| Avg Closing Trade (30 D): |
$1.06M |
| Avg Closing Trade (90 D): |
$1.24M |
| Avg Closing Volume: |
73.29K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$.58
|
$.07
|
|
|
Diluted EPS
|
$.57
|
$.07
|
|
|
Revenue
|
$80.33M
|
$19.99M
|
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$29.34M
|
$3.62M
|
|
|
Operating Income / Loss
|
$-32.81M
|
$-6.46M
|
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$151.4M
|
|
|
|
PE Ratio
|
33.98
|
|
|
|
|
|
